Christine Erikstrup Hallgreen

Christine Erikstrup Hallgreen

Associate Professor

Member of:

    ORCID: 0000-0002-7916-3915

    Publication year:
    All
    21 - 30 out of 35Page size: 10
    1. 2020
    2. Published

      Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies: A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges

      Ofori-Asenso, R., Hallgreen, Christine Erikstrup & De Bruin, M. L., 2020, In: Frontiers in Medicine. 7, 17 p., 582634.

      Research output: Contribution to journal › Review › Research › peer-review

    3. 2019
    4. Published

      Impact of European Benefit-Risk reassessment procedures on drug prescribing practices in Denmark

      De Bruin, M. L. (., Hallgreen, Christine Erikstrup & Andersen, Morten, Aug 2019.

      Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

    5. Published

      The effectiveness of direct to healthcare professional communication – A systematic review of communication factor studies

      Møllebæk, Mathias, Kaae, Susanne, De Bruin, M. L., Callréus, T., Jossan, S. & Hallgreen, Christine Erikstrup, May 2019, In: Research in Social and Administrative Pharmacy. 15, 5, p. 475-482

      Research output: Contribution to journal › Review › Research › peer-review

    6. 2018
    7. Published

      Impact of the 2012 pharmacovigilance legislation on the harmonisation of DHPCS in the EU

      Olafsdottir, G., Bukhave, S. M., Kalligeros, G., Hallgreen, Christine Erikstrup & De Bruin, M. L., Aug 2018, p. 515-516.

      Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

    8. 2017
    9. Published

      How to Measure the Impact of Pharmacovigilance Activities on Public Health?

      Gardarsdottir, H., Kant, A., De Bruin, M. L., Hallgreen, Christine Erikstrup, Dal Pan, G. & Way, D., Aug 2017, p. 31-31.

      Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

    10. Published

      Differences and similarities in medicine use, perceptions and sharing among adolescents in two different educational settings

      Vestergaard, Stense Kromann, Hallgreen, Christine Erikstrup, Ravn, P. & Kaae, Susanne, 2017, In: International Journal of Adolescent Medicine and Health. DOI: https://doi.org/10.1515/ijamh-2017-0097, 9 p., 0097.

      Research output: Contribution to journal › Journal article › Research › peer-review

    11. 2016
    12. Published

      Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance

      Aagaard, L., Hallgreen, Christine Erikstrup & Hansen, E. H., Nov 2016, In: International journal of obesity (2005). 40, 11, p. 1742-1747 6 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    13. Literature review of visual representation of the results of benefit-risk assessments of medicinal products

      Hallgreen, Christine Erikstrup, Mt-Isa, S., Lieftucht, A., Phillips, L. D., Hughes, D., Talbot, S., Asiimwe, A., Downey, G., Genov, G., Hermann, R., Noel, R., Peters, R., Micaleff, A., Tzoulaki, I., Ashby, D. & PROTECT Benefit-Risk Group, P. B. G., Mar 2016, In: Pharmacoepidemiology and Drug Safety. 25, 3, p. 238-50 13 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    14. Published

      Recommendations for benefit-risk assessment methodologies and visual representations

      Hughes, D., Waddingham, E., Mt-Isa, S., Goginsky, A., Chan, E., Downey, G. F., Hallgreen, Christine Erikstrup, Hockley, K. S., Juhaeri, J., Lieftucht, A., Metcalf, M. A., Noel, R. A., Phillips, L. D., Ashby, D., Micaleff, A. & PROTECT Benefit-Risk Group, P. B. G., Mar 2016, In: Pharmacoepidemiology and Drug Safety. 25, 3, p. 251-62 12 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    15. 2014

    16. Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology

      Hallgreen, C. E., van den Ham, H. A., Mt-Isa, S., Ashworth, S., Hermann, R., Hobbiger, S., Luciani, D., Micaleff, A., Thomson, A., Wang, N., van Staa, T. P., Downey, G., Hirsch, I., Hockley, K., Juhaeri, J., Metcalf, M., Mwangi, J., Nixon, R., Peters, R., Stoeckert, I. & 4 others, Waddingham, E., Tzoulaki, I., Ashby, D. & Wise, L., Sep 2014, In: Pharmacoepidemiology and Drug Safety. 23, 9, p. 974-983 10 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    Previous 1 2 3 4 Next

    ID: 122745397